{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:09:53Z","timestamp":1746850193315,"version":"3.40.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Alcohol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.alcohol.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:38:28Z","timestamp":1742067508000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The use of baclofen to reduce alcohol-attributable hospitalizations and emergency department admissions"],"prefix":"10.1016","volume":"125","author":[{"given":"Ming-Chyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-1901","authenticated-orcid":false,"given":"Yu-Hsuan Joni","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.alcohol.2025.03.002_bib1","first-page":"67","article-title":"Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence","volume":"24","author":"Addolorato","year":"2000","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"5","key":"10.1016\/j.alcohol.2025.03.002_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","article-title":"Baclofen efficacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study","volume":"37","author":"Addolorato","year":"2002","journal-title":"Alcohol and Alcoholism"},{"issue":"9603","key":"10.1016\/j.alcohol.2025.03.002_bib3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: Randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.alcohol.2025.03.002_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/alcalc\/agr017","article-title":"Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: Secondary analysis of a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Addolorato","year":"2011","journal-title":"Alcohol and Alcoholism"},{"issue":"1","key":"10.1016\/j.alcohol.2025.03.002_bib5","article-title":"Baclofen for alcohol use disorder","volume":"1","author":"Agabio","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.alcohol.2025.03.002_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/alcalc\/agh130","article-title":"Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: A self-case report of a physician","volume":"40","author":"Ameisen","year":"2005","journal-title":"Alcohol and Alcoholism"},{"issue":"10","key":"10.1016\/j.alcohol.2025.03.002_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/MEG.0000000000000922","article-title":"One year of baclofen in 100 patients with or without cirrhosis: A French real-life experience","volume":"29","author":"Barrault","year":"2017","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"12","key":"10.1016\/j.alcohol.2025.03.002_bib8","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","article-title":"Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial","volume":"26","author":"Beraha","year":"2016","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.alcohol.2025.03.002_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.amepre.2011.06.045","article-title":"Economic costs of excessive alcohol consumption in the U.S., 2006","volume":"41","author":"Bouchery","year":"2011","journal-title":"American Journal of Preventive Medicine"},{"issue":"5","key":"10.1016\/j.alcohol.2025.03.002_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF03033315","article-title":"Role of GABA(B) receptor in alcohol dependence: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics","volume":"6","author":"Colombo","year":"2004","journal-title":"Neurotoxicity Research"},{"issue":"15","key":"10.1016\/j.alcohol.2025.03.002_bib11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2012.482","article-title":"Is it time for medicine-based evidence?","volume":"307","author":"Concato","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpsyt.2012.00103","article-title":"Suppression of alcohol dependence using baclofen: A 2-year observational study of 100 patients","volume":"3","author":"de Beaurepaire","year":"2012","journal-title":"Frontiers in Psychiatry"},{"issue":"2","key":"10.1016\/j.alcohol.2025.03.002_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/alcalc\/agad090","article-title":"Baclofen in the treatment of alcohol use disorder: Tailored doses matter","volume":"59","author":"de Beaurepaire","year":"2024","journal-title":"Alcohol and Alcoholism"},{"key":"10.1016\/j.alcohol.2025.03.002_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fpsyt.2018.00708","article-title":"The use of baclofen as a treatment for alcohol use disorder: A clinical practice perspective","volume":"9","author":"de Beaurepaire","year":"2018","journal-title":"Frontiers in Psychiatry"},{"issue":"5","key":"10.1016\/j.alcohol.2025.03.002_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/JCP.0b013e3182983e73","article-title":"Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: A multivariate meta-analysis examining change over time","volume":"33","author":"Del Re","year":"2013","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.alcohol.2025.03.002_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0306-4603(98)00023-9","article-title":"Frequent childhood geographic relocation: Its impact on drug use initiation and the development of alcohol and other drug-related problems among adolescents and young adults","volume":"23","author":"Dewit","year":"1998","journal-title":"Addictive Behaviors"},{"issue":"10","key":"10.1016\/j.alcohol.2025.03.002_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012182","article-title":"Psychotropic drug use and alcohol consumption among older adults in Germany: Results of the German health interview and examination survey for adults 2008\u20132011","volume":"6","author":"Du","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.alcohol.2025.03.002_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.euroneuro.2013.09.008","article-title":"Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns--a cohort study","volume":"24","author":"Dupouy","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.alcohol.2025.03.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/syn.10238","article-title":"Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat","volume":"50","author":"Fadda","year":"2003","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.alcohol.2025.03.002_bib20","first-page":"1164","article-title":"Prescribing guide for baclofen in the treatment of alcoholism \u2013 for use by physicians","volume":"4","author":"Gache","year":"2013","journal-title":"Journal of Advances in Medicine and Medical Research"},{"issue":"11","key":"10.1016\/j.alcohol.2025.03.002_bib21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: A randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"13","key":"10.1016\/j.alcohol.2025.03.002_bib22","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41386-021-01055-w","article-title":"Efficacy and tolerability of baclofen in a U.S. Community population with alcohol use disorder: A dose-response, randomized, controlled trial","volume":"46","author":"Garbutt","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.alcohol.2025.03.002_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0376-8716(95)01160-4","article-title":"Comorbidity between DSM-IV alcohol use disorders and major depression: Results of a national survey","volume":"39","author":"Grant","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 7","key":"10.1016\/j.alcohol.2025.03.002_bib24","first-page":"S3","article-title":"New Australian guidelines for the treatment of alcohol problems: An overview of recommendations","volume":"215","author":"Haber","year":"2021","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"10.1016\/j.alcohol.2025.03.002_bib25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamapsychiatry.2021.1271","article-title":"Use of medications for alcohol use disorder in the US: Results from the 2019 national survey on drug use and health","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.alcohol.2025.03.002_bib26","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/add.13787","article-title":"The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: A randomized controlled trial","volume":"112","author":"Hauser","year":"2017","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.alcohol.2025.03.002_bib27","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3109\/16066359.2015.1040003","article-title":"Tailored dose baclofen in patients with alcoholic liver disease: A case series with 2-year follow-up of hospitalisation","volume":"23","author":"Heydtmann","year":"2015","journal-title":"Addiction Research and Theory"},{"key":"10.1016\/j.alcohol.2025.03.002_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan's national health insurance research database: Past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clinical Epidemiology"},{"issue":"3","key":"10.1016\/j.alcohol.2025.03.002_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/13556210500223504","article-title":"A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan","volume":"10","author":"Huang","year":"2005","journal-title":"Addiction Biology"},{"key":"10.1016\/j.alcohol.2025.03.002_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02638-x","article-title":"Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review","author":"Huneke","year":"2024","journal-title":"Molecular Psychiatry"},{"issue":"18","key":"10.1016\/j.alcohol.2025.03.002_bib31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2025.03.002_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/B978-0-444-62619-6.00007-0","article-title":"Alcohol: Intoxication and poisoning - diagnosis and treatment","volume":"125","author":"Jung","year":"2014","journal-title":"Handbook of Clinical Neurology"},{"issue":"7","key":"10.1016\/j.alcohol.2025.03.002_bib33","doi-asserted-by":"crossref","first-page":"e642","DOI":"10.4088\/JCP.12r08178","article-title":"Antipsychotics for primary alcohol dependence: A systematic review and meta-analysis of placebo-controlled trials","volume":"74","author":"Kishi","year":"2013","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1016\/j.alcohol.2025.03.002_bib34","first-page":"1335","article-title":"Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis","volume":"25","author":"Kranzler","year":"2001","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"6","key":"10.1016\/j.alcohol.2025.03.002_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.17116\/jnevro20151156153-62","article-title":"[Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan\u00ae) for alcohol dependence]","volume":"115","author":"Krupitsky","year":"2015","journal-title":"Zhurnal Nevrologii I Psikhiastrii Imeni S. S. Korsakova"},{"issue":"1","key":"10.1016\/j.alcohol.2025.03.002_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/alcalc\/agm136","article-title":"A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence","volume":"43","author":"Laaksonen","year":"2008","journal-title":"Alcohol and Alcoholism"},{"issue":"1","key":"10.1016\/j.alcohol.2025.03.002_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-014-3652-9","article-title":"A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers","volume":"232","author":"Leggio","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.alcohol.2025.03.002_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/alcalc\/33.6.563","article-title":"Benzodiazepine treatment for alcohol-dependent patients","volume":"33","author":"Lejoyeux","year":"1998","journal-title":"Alcohol and Alcoholism"},{"issue":"3","key":"10.1016\/j.alcohol.2025.03.002_bib39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1369-1600.2012.00454.x","article-title":"Medications development to treat alcohol dependence: A vision for the next decade","volume":"17","author":"Litten","year":"2012","journal-title":"Addiction Biology"},{"issue":"8","key":"10.1016\/j.alcohol.2025.03.002_bib40","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.euroneuro.2015.04.002","article-title":"High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial","volume":"25","author":"M\u00fcller","year":"2015","journal-title":"European Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.alcohol.2025.03.002_bib41","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.15288\/jsa.1976.37.1215","article-title":"The diagnosis of pathological intoxication","volume":"37","author":"Maletzky","year":"1976","journal-title":"Journal of Studies on Alcohol"},{"issue":"6","key":"10.1016\/j.alcohol.2025.03.002_bib42","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/alcalc\/agu062","article-title":"Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety","volume":"49","author":"Morley","year":"2014","journal-title":"Alcohol and Alcoholism"},{"year":"2013","series-title":"No.1 national health interview survey","key":"10.1016\/j.alcohol.2025.03.002_bib43"},{"issue":"2","key":"10.1016\/j.alcohol.2025.03.002_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/JCP.0b013e31824929b2","article-title":"High-dose baclofen for treatment-resistant alcohol dependence","volume":"32","author":"Pastor","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"10","key":"10.1016\/j.alcohol.2025.03.002_bib45","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.alcohol.2025.03.002_bib46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2018.03.017","article-title":"Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis","volume":"28","author":"Pierce","year":"2018","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.alcohol.2025.03.002_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2593","article-title":"The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study","volume":"32","author":"Pignon","year":"2017","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.alcohol.2025.03.002_bib48","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fpsyt.2018.00486","article-title":"Tailored-dose baclofen in the management of alcoholism: A retrospective study of 144 outpatients followed for 3 Years in a French general practice","volume":"9","author":"Pinot","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.alcohol.2025.03.002_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jsat.2014.11.007","article-title":"Baclofen as add-on to standard psychosocial treatment for alcohol dependence: A randomized, double-blind, placebo-controlled trial with 1 year follow-up","volume":"52","author":"Ponizovsky","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"19","key":"10.1016\/j.alcohol.2025.03.002_bib50","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiologic catchment area (ECA) study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.alcohol.2025.03.002_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American psychiatric association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.alcohol.2025.03.002_bib52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/alcalc\/agx030","article-title":"A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients-the ALPADIR study","volume":"52","author":"Reynaud","year":"2017","journal-title":"Alcohol and Alcoholism"},{"issue":"4","key":"10.1016\/j.alcohol.2025.03.002_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/alcalc\/ags028","article-title":"Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: A retrospective study among 'high-risk' drinkers","volume":"47","author":"Rigal","year":"2012","journal-title":"Alcohol and Alcoholism"},{"issue":"5","key":"10.1016\/j.alcohol.2025.03.002_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/alcalc\/agv052","article-title":"Tolerability of high-dose baclofen in the treatment of patients with alcohol disorders: A retrospective study","volume":"50","author":"Rigal","year":"2015","journal-title":"Alcohol and Alcoholism"},{"issue":"7","key":"10.1016\/j.alcohol.2025.03.002_bib55","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/add.14927","article-title":"Titrated baclofen for high-risk alcohol consumption: A randomized placebo-controlled trial in out-patients with 1-year follow-up","volume":"115","author":"Rigal","year":"2020","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.alcohol.2025.03.002_bib56","first-page":"27","article-title":"Recent developments in alcohol Services research on access to care","volume":"38","author":"Schmidt","year":"2016","journal-title":"Alcohol Res"},{"issue":"7","key":"10.1016\/j.alcohol.2025.03.002_bib57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40264-016-0416-y","article-title":"Safety and tolerability of pharmacological treatment of alcohol dependence: Comprehensive review of evidence","volume":"39","author":"Sinclair","year":"2016","journal-title":"Drug Safety"},{"issue":"10","key":"10.1016\/j.alcohol.2025.03.002_bib58","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1360-0443.1991.tb01703.x","article-title":"A meta-analysis of change in marital and employment status as predictors of alcohol consumption on a typical occasion","volume":"86","author":"Temple","year":"1991","journal-title":"British Journal of Addiction"},{"issue":"9422","key":"10.1016\/j.alcohol.2025.03.002_bib59","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(04)16261-2","article-title":"When are observational studies as credible as randomised trials?","volume":"363","author":"Vandenbroucke","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.alcohol.2025.03.002_bib60","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S0950268811001531","article-title":"Use of the self-controlled case-series method in vaccine safety studies: Review and recommendations for best practice","volume":"139","author":"Weldeselassie","year":"2011","journal-title":"Epidemiology and Infection"},{"issue":"4","key":"10.1016\/j.alcohol.2025.03.002_bib61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-148-4-200802190-00004","article-title":"A 10-year experience with universal health insurance in Taiwan: Measuring changes in health and health disparity","volume":"148","author":"Wen","year":"2008","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1016\/j.alcohol.2025.03.002_bib62","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: The self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Statistics in Medicine"}],"container-title":["Alcohol"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832925000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832925000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T17:44:57Z","timestamp":1746812697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741832925000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":62,"alternative-id":["S0741832925000382"],"URL":"https:\/\/doi.org\/10.1016\/j.alcohol.2025.03.002","relation":{},"ISSN":["0741-8329"],"issn-type":[{"type":"print","value":"0741-8329"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of baclofen to reduce alcohol-attributable hospitalizations and emergency department admissions","name":"articletitle","label":"Article Title"},{"value":"Alcohol","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alcohol.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}